Podcast cover
John Coogan & Jordi Hays · Technology

TBPN

TBPN is a live tech talk show hosted by John Coogan and Jordi Hays, streaming weekdays from 11–2 PT on X and YouTube, with full episodes posted to Spotify immediately after airing. Described by The New York Times as “Silicon Valley’s newest obsession,” TBPN has interviewed Mark Zuckerberg, Sam Altman, Mark Cuban, and Satya Nadella. Diet TBPN delivers the best moments from each episode in under 30 minutes.

Episodes

Episode cover

Meta Drops New Model, Mythos, RoboLamp | Luther Lowe, Dan Primack, Lior Susan, Feross Aboukhadijeh, Qasim Mithani, Jaleh Rezaei, Jeremy Philip Galen

08 Apr 2026
2h 18m
Episode cover

Meta Tokenmaxxing, Intel Joins Terafab, Frontier AI vs. China | Diet TBPN

08 Apr 2026
33m
AI processed

The podcast examines the trend of Meta employees competing for token usage, questioning its effectiveness and potential cost implications for Anthropic. It explores whether "token maxing" is a misguided metric, referencing Goodhart's Law and contrasting it with Meta's AI-driven successes in ad targeting. The conversati...

Episode cover

FULL INTERVIEW: Thomas Laffont’s Journey From Hollywood Assistant to Legendary Tech Investor

07 Apr 2026
1h 2m
AI processed

Thomas Laffont from Co2 discusses his career trajectory from a French language school in New York to Yale, then to the mailroom at CAA, and eventually into the world of venture capital. Laffont emphasizes the importance of building one's own models to truly understand an investment thesis, drawing parallels between pit...

Episode cover

Tokenmaxxing, SF Street Name Auction, Corporate Retreat Gone Wrong | Riley Walz, Aditya Bandi, Zach Shore, Hongwei Liu, Zak Kukoff, Thomas Laffont

07 Apr 2026
3h 14m
Episode cover

The $1B One-Person Company, China’s Pork Crisis, America’s New Weapon | Diet TBPN

06 Apr 2026
30m
Episode cover

$1B GLP-1 Lessons, New AI Careers, China's 2030 Master Plan | Sam Broner, Jonathan Slotkin, Liz Hoffman, Bret Taylor, Ariyan Kabir, Atif Siddiqi

06 Apr 2026
2h 38m
Episode cover

Open AI Acquires TBPN, Artemis II, The AI-Built $1.8B Company | Diet TBPN

03 Apr 2026
31m
Episode cover

OpenAI Acquires TBPN

02 Apr 2026
3h 0m
Episode cover

Artemis II, Jamie Dimon’s “American Dream,” Snap’s Crucible Moment | Diet TBPN

02 Apr 2026
31m
Episode cover

FULL INTERVIEW: Apple Exec on How Apple Builds Products That Actually Win

01 Apr 2026
22m
Episode cover

Eddy Cue Joins for Apple's 50th, Artemis Launch, Jamie Dimon's Plan, Save Snap Now, SpaceX IPO | Aaron Terrazas, Pratap Ranade, Abhishek Das, Garry Tan, Brannin McBee, Sam Yagan

01 Apr 2026
3h 24m
Episode cover

AI Is Coming for Your Memes, Crypto’s Quantum Clock, Axios Hack| Diet TBPN

01 Apr 2026
30m
Episode cover

AI Is Coming for Your Memes, Axios NPM Package Compromised, Claude Code Source Code Leak | Alex Pruden, Qasar Younis, Sebastian Mallaby, Forrest Heath, Dino Mavrookas, Will Ahmed, Jannick Malling, Ryan Daniels, Chris Yu

31 Mar 2026
3h 8m
Episode cover

Social Media Placebo Trial, Jetsons Nailed AI, Artemis II: Back To The Moon | Diet TBPN

31 Mar 2026
31m
Episode cover

FULL INTERVIEW: Why I Think Nvidia Is Perfectly Positioned In The AI Race

30 Mar 2026
29m
Episode cover

The Lawyer Who Beat Meta and Google, Revisiting The Jetsons, Japan Twitter | Tae Kim, Logan Bartlett, Sam Stephenson, Ben Broca, Brett Adcock, Andrei Serban

30 Mar 2026
3h 0m
AI processed

The podcast explores the intersection of social media, technology, and potential legal ramifications, highlighting a case where Meta and YouTube were found negligent in designing addictive apps harmful to teens. The hosts examine attorney Mark Lanier's successful strategies in arguing against tech giants, including his...

Episode cover

Novartis Buys Excellergy for $2B, Anthropic Vs. Pentagon, The Mansion Section | Diet TBPN

28 Mar 2026
32m
Episode cover

$2B Allergy Drug, ChatGPT Ads, Mansion Section | Billy Boman, Benjamin Miller, Faris Sbahi, Evan Loomis, Anvisha Pai, Ryan Tseng

27 Mar 2026
2h 39m
AI processed

The hosts discuss AI's growing impact across various sectors, from pharmaceutical advancements to creative advertising and defense technology. They analyze Novartis' acquisition of Excellergy for its allergy drug research, highlighting the biotech playbook and AI's role in streamlining FDA filings. The conversation shi...

Episode cover

How I Built and Sold SALT & STONE

27 Mar 2026
28m
Episode cover

Arm’s $15B Chip Bet, Sanders & AOC vs Datacenters, Meta & YouTube Lose Trial | Diet TBPN

27 Mar 2026
31m
Page 12

Follow this podcast in Podwise

Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.

Open in Podwise